Ticker Scorecard - OVID Basics Company: Ovid Therapeutics Inc. IPO Date: May 10, 2017 Sector: Healthcare Industry: Biotech Market Cap: $43.85M Activated in VL: True Average Daily Range Avg Daily Range: $0.14 | 3.22% Avg Daily Range (30 D): $0.03 | 4.07% Avg Daily Range (90 D): $0.03 | 3.36% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): .32M Avg Daily Volume (90 D): .23M Trade Size Avg Trade Size (Sh.): 191 Avg Trade Size (Sh.) (30 D): 296 Avg Trade Size (Sh.) (90 D): 201 Institutional Trades Total Inst.Trades: 112 Avg Inst. Trade: $2.13M Avg Inst. Trade (30 D): $.59M Avg Inst. Trade (90 D): $.59M Avg Inst. Trade Volume: .48M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.5M Avg Closing Trade (30 D): $.6M Avg Closing Trade (90 D): $.6M Avg Closing Volume: 712.2K     News Feb 20, 2025 @ 6:00 PM Epilepsy Market Assessment in the 7MM by 2034 ââ‚... Source: Delveinsight Feb 5, 2025 @ 1:00 PM Ovid Therapeutics to Present at the Oppenheimer 35... Source: N/A Jul 1, 2024 @ 12:00 PM Ovid Therapeutics and Graviton Bioscience Announce... Source: Ovid Therapeutics Inc. Jun 30, 2024 @ 1:10 PM Wall Street Breakfast: The Week Ahead Source: Wall Street Breakfast Jun 20, 2024 @ 3:39 PM Biotech Stock Roundup: ITCI Up on Study Data, ZNTL... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.46 $-.2 $.12 Diluted EPS $-.46 $-.2 $.12 Revenue $ .63M $ .17M $ .17M Gross Profit $ $ $ Net Income / Loss $ -32.5M $ -14.01M $ 8.52M Operating Income / Loss $ -69.35M $ -13.23M $ -20.52M Cost of Revenue $ $ $ Net Cash Flow $ -42.42M $ -14.68M $ -1.08M PE Ratio